Merck to buy Prometheus Biosciences for about $11 billion
April 16 (Reuters) - Merck & Co (MRK.N) said on Sunday it will buy Prometheus Biosciences Inc (RXDX.O) for about $10.8 billion, picking up a promising experimental treatment for ulcerative...
Merck’s $10.8 billion takeover of Prometheus gives it a foothold …
Apr 18, 2023 · Merck & Co.’s $10.8 billion acquisition of Prometheus Biosciences Inc., which it announced Sunday, is a strategic positive that will help the drug company diversify its portfolio and reduce the...
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus …
Apr 16, 2023 · Prometheus is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases.
Prometheus (RXDX) Stock Surges 70% on Buyout Offer From Merck
Apr 17, 2023 · Prometheus (RXDX) is set to be acquired by Merck for $11 billion, adding Prometheus' lead product candidate, PRA023, to Merck's portfolio. Prometheus' stock is up 70%.
Merck buys Prometheus Biosciences for almost $11bn - Financial Times
Apr 16, 2023 · Merck has agreed to buy Prometheus Biosciences for $10.8bn as the US drugmaker bolsters it pipeline ahead of the possible loss of exclusivity over its best-selling cancer drug later this decade.
Merck Completes Acquisition of Prometheus Biosciences, Inc.
Jun 16, 2023 · Merck Completes Acquisition of Prometheus Biosciences, Inc. Save. June 16, 2023 4:04 pm ET. Acquisition delivers industry-leading research capability, and strengthens pipeline with a novel candidate for ulcerative colitis, Crohn’s disease and …
Prometheus Biosciences Announces Positive Results for PRA023 …
Dec 7, 2022 · Prometheus Biosciences Announces Positive Results for PRA023 in Both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Studies Enabling Pathway to Both First-in-Class and Best-in-Class Anti-TL1A mAb....
Merck Acquires Prometheus Biosciences for $10.8 Billion - Investopedia
Apr 17, 2023 · Merck agreed to acquire Prometheus Biosciences in a deal worth $10.8 billion. Shares of Prometheus Biosciences were up 70% in early trading on Monday following the announcement.
Prometheus Biosciences Reports First Quarter 2023 Financial …
May 9, 2023 · Prometheus Biosciences, Inc. is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutics for the...
‘Who the hell’ is Prometheum and what did it say to Congress …
Jun 15, 2023 · Aaron Kaplan, the co-founder of blockchain company Prometheum, provided testimony at a Congressional hearing with favorable opinions of the SEC, a stark comparison from other crypto industry...